The spread of breast cancer cells to lymph nodes under the arm is a significant indication of the stage of the disease and the patient's prognosis, and lymph node biopsies or even surgical removal often are needed to determine whether metastasis has occurred.
In an effort to develop noninvasive options to assess lymph node involvement, PET scans (positron emission tomography) and other technologies are being refined and studied for their ability to detect breast cancer cells in lymph nodes. But while noninvasive imaging procedures offer reduced discomfort and risk, scans may be open to interpretation when analyzed visually.
PET scans for invasive breast cancers and their metastases are performed after injection of a glucose-like substance called fludeoxyglucose F 18 (FDG) and a radioactive tracer. Because malignant cells use more glucose than normal cells, FDG accumulates in them and the tracer makes them visible on the PET scan.
The key to accurate diagnosis, according to the article, is the amount of tracer uptake – a "standardized uptake value" (SUV). At Cedars-Sinai, axillary nodes with SUVs of 2.3 or greater were 15 times more likely to contain metastasis than nodes with SUVs less than 2.3. In fact, with the SUV threshold set at 2.3, 60 percent of those with axillary metastases were identified (60 percent sensitivity), there were no false positive readings (100 percent specificity) and all those with a positive result were accurately diagnosed (100 percent positive predictive value). Accuracy was 72 percent.
"The purpose of the article is not to advocate using PET scans to detect axillary node metastasis but to suggest that if physicians are going to perform a PET scan before surgery for systemic staging, an SUV should be calculated. PET should be performed and interpreted in the proper clinical context, and SUVs should be used as an adjunct to clinical judgment," said Edward H. Phillips, MD, the paper's senior author who is executive vice chairman of Cedars-Sinai's Department of Surgery, chief of the Division of General Surgery, and director of the Saul and Joyce Brandman Breast Center.
Although Cedars-Sinai's threshold was 2.3, that number is expected to vary from one institution to another because of technical and calibration factors. Therefore, each PET center is advised to develop it own reference values.
"FDG-PET is not a perfect test, but by quantifying the cancer-cell activity in the axillary lymph nodes, it can become a more accurate test," said Phillips. "As we continue to see advances in technologies, I believe we will be able to identify smaller and smaller tumors with greater accuracy."
In their study, the researchers reviewed the medical records of 462 women with invasive breast cancer who underwent FDG-PET for staging at the Saul and Joyce Brandman Breast Center between Nov. 1, 2001 and Aug. 31, 2005. The study focused on the cases of 51 women (with 54 invasive cancers) who had PET scanning performed before undergoing axillary lymph node surgery or chemotherapy.
It was determined an SUV greater than 2.3 was sufficient to diagnose lymph node involvement, and that there would be no need for sentinel lymph node biopsy or needle biopsy. The study suggests that with SUV validation of metastasis, chemotherapy can be initiated or the surgeon can proceed directly to axillary lymph node dissection to control the spread of the disease.
Research offers clues for improved influenza vaccine design
09.04.2018 | NIH/National Institute of Allergy and Infectious Diseases
Injecting gene cocktail into mouse pancreas leads to humanlike tumors
06.04.2018 | University of Texas Health Science Center at San Antonio
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.
Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
19.04.2018 | Materials Sciences
19.04.2018 | Physics and Astronomy
19.04.2018 | Physics and Astronomy